POLICE COOPERATION AS A RESPONSE TO EUROPEAN UNION SECURITY THREATS
Studia Administracji i Bezpieczeństwa · 30.12.2025 · 19 (19) · 255-272
DOI: 10.5604/01.3001.0055.6413 ↗Kurz gefasst
Fachartikel in der Zeitschrift Studia Administracji i Bezpieczeństwa, erschienen am 30.12.2025. Verfasst von Maria Hapunik. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
This paper examines the rapidly evolving police cooperation within the European Union, which represents a crucial and essential response to emerging internal security threats. This article focuses on developments since 2022, examining enhanced legal and operational frameworks, including Europol's expanded mandate, the role of the European Multidisciplinary Platform Against Criminal Threats (EMPACT), and the integration of innovative technologies such as artificial intelligence (AI) and advanced biometric systems. The research demonstrates the indispensability of police cooperation in addressing organized crime, cybercrime, migration crisis management, and hybrid threats. Furthermore, the study identifies that the effectiveness of police cooperation is directly contingent upon the interoperability of information systems, mutual trust among EU member states, and response capabilities to contemporary challenges, while maintaining robust standards for fundamental rights protection and citizen privacy.
Zitieren
APA
Hapunik, M. (2025). POLICE COOPERATION AS A RESPONSE TO EUROPEAN UNION SECURITY THREATS. Studia Administracji i Bezpieczeństwa, 19(19), 255-272. https://doi.org/10.5604/01.3001.0055.6413
Vancouver
Hapunik M. POLICE COOPERATION AS A RESPONSE TO EUROPEAN UNION SECURITY THREATS. Studia Administracji i Bezpieczeństwa. 2025;19(19):255-272. doi:10.5604/01.3001.0055.6413
BibTeX
@article{Hapunik2025,
author = {Hapunik, Maria},
title = {POLICE COOPERATION AS A RESPONSE TO EUROPEAN UNION SECURITY THREATS},
journal = {Studia Administracji i Bezpieczeństwa},
year = {2025},
volume = {19},
number = {19},
pages = {255--272},
doi = {10.5604/01.3001.0055.6413}
}
EUVIMED